205 related articles for article (PubMed ID: 21638519)
1. CBFB and MYH11 in inv(16)(p13q22) of acute myeloid leukemia displaying close spatial proximity in interphase nuclei of human hematopoietic stem cells.
Weckerle AB; Santra M; Ng MC; Koty PP; Wang YH
Genes Chromosomes Cancer; 2011 Sep; 50(9):746-55. PubMed ID: 21638519
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of additional chromosomal abnormalities in adult acute myeloid leukemia with inv (16)/t(16;16)/CBFB::MYH11.
Gao J; Santana-Santos L; Fu L; Alvey E; Chen Q; Wolniak K; Xia Z; Aqil B; Behdad A; Ji P; Sukhanova M; Abaza Y; Altman JK; Chen YH; Lu X
Eur J Haematol; 2024 Jun; 112(6):964-974. PubMed ID: 38388794
[TBL] [Abstract][Full Text] [Related]
3. Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patients.
Schnittger S; Bacher U; Haferlach C; Kern W; Haferlach T
Leukemia; 2007 Apr; 21(4):725-31. PubMed ID: 17287858
[TBL] [Abstract][Full Text] [Related]
4. Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.
Saida S; Zhen T; Kim E; Yu K; Lopez G; McReynolds LJ; Liu PP
Leukemia; 2020 Mar; 34(3):759-770. PubMed ID: 31624376
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with t(16;16) (p13;q22) showing a new CBFB-MYH11 fusion transcript associated with an atypical leukemic blasts morphology.
Albano F; Anelli L; Zagaria A; Coccaro N; Tota G; Impera L; Minervini CF; Cellamare A; Delia M; Minervini A; Casieri P; Specchia G
Hum Pathol; 2014 Mar; 45(3):643-7. PubMed ID: 24342433
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
[TBL] [Abstract][Full Text] [Related]
7.
Wang L; Wang W; Beird HC; Cheng X; Fang H; Tang G; Toruner GA; Yin CC; You MJ; Issa GC; Borthakur G; Peng G; Khoury JD; Medeiros LJ; Tang Z
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011278
[TBL] [Abstract][Full Text] [Related]
8. Detection of a novel CBFB-MYH11 fusion transcript in acute myeloid leukemia M1 with inv(16)(p13q22).
Kurata K; Yamamoto K; Okazaki Y; Noguchi Y; Matsui K; Matsumoto H; Inui Y; Yakushijin K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Minami H
Cancer Genet; 2020 Feb; 241():72-76. PubMed ID: 31353165
[TBL] [Abstract][Full Text] [Related]
9. [Acute myeloid leukemia with type I CBFB::MYH11 fusion gene not detected by screening test for leukemia-related chimeric genes].
Utsumi S; Shima T; Kubara C; Semba Y; Hayashi M; Takigawa K; Yoshino T; Minami M; Matsuo Y; Kuriyama T; Akashi K; Maeda T; Taniguchi S; Eto T
Rinsho Ketsueki; 2023; 64(12):1503-1507. PubMed ID: 38220149
[TBL] [Abstract][Full Text] [Related]
10. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
[TBL] [Abstract][Full Text] [Related]
11. Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia.
Clarke S; de Kraa R; Chuah H; Creeper K; Leahy MF; Wright M
Cancer Genet; 2022 Aug; 266-267():7-14. PubMed ID: 35613501
[TBL] [Abstract][Full Text] [Related]
12. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
Castilla LH; Bushweller JH
Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
[TBL] [Abstract][Full Text] [Related]
13. The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis.
Duan W; Liu X; Jia J; Wang J; Gong L; Jiang Q; Zhao T; Wang Y; Zhang X; Xu L; Zhao X; Qin Y; Shi H; Chang Y; Huang X; Jiang H
Br J Haematol; 2021 Jan; 192(2):265-271. PubMed ID: 32588434
[TBL] [Abstract][Full Text] [Related]
14. Incidental identification of inv(16)(p13.1q22)/
Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
[TBL] [Abstract][Full Text] [Related]
15. Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits.
Park TS; Lee ST; Song J; Lee KA; Lee JH; Kim J; Lee HJ; Han JH; Kim JK; Cho SR; Choi JR
Cancer Genet Cytogenet; 2009 Mar; 189(2):87-92. PubMed ID: 19215788
[TBL] [Abstract][Full Text] [Related]
16. Detection of del(16q) using the CBFB-MYH11 translocation dual fusion probe.
Temerik DF; El-Mahdy WT; Ahmed AM
Hematol Oncol Stem Cell Ther; 2021 Dec; 14(4):351-352. PubMed ID: 32202250
[TBL] [Abstract][Full Text] [Related]
17. Myeloid Sarcoma With CBFB-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen.
Dalland JC; Meyer R; Ketterling RP; Reichard KK
Am J Clin Pathol; 2020 Feb; 153(3):333-341. PubMed ID: 31671434
[TBL] [Abstract][Full Text] [Related]
18. CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia.
Mandoli A; Singh AA; Jansen PW; Wierenga AT; Riahi H; Franci G; Prange K; Saeed S; Vellenga E; Vermeulen M; Stunnenberg HG; Martens JH
Leukemia; 2014 Apr; 28(4):770-8. PubMed ID: 24002588
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11.
Cho BS; Min GJ; Park SS; Park S; Jeon YW; Shin SH; Yahng SA; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
Bone Marrow Transplant; 2021 Nov; 56(11):2682-2689. PubMed ID: 34183780
[TBL] [Abstract][Full Text] [Related]
20. CBFB-MYH11 fusion neoantigen enables T cell recognition and killing of acute myeloid leukemia.
Biernacki MA; Foster KA; Woodward KB; Coon ME; Cummings C; Cunningham TM; Dossa RG; Brault M; Stokke J; Olsen TM; Gardner K; Estey E; Meshinchi S; Rongvaux A; Bleakley M
J Clin Invest; 2020 Oct; 130(10):5127-5141. PubMed ID: 32831296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
